Global pharmaceutical giant Novartis teams up with billionaire-backed Canadian marijuana startup

Novartis AG is partnering with a Canadian cannabis company backed by billionaire Peter Thiel to get in on the medical marijuana business. The health-care giant’s Sandoz Canada division is forming a strategic alliance with Tilray, which makes cannabis medicines in capsules and other forms. Together, the companies will develop new pot-based medications and Sandoz would…